- Report
- January 2023
- 127 Pages
North America
From €3140EUR$3,450USD£2,667GBP
- Report
- January 2023
- 166 Pages
Asia Pacific
From €3140EUR$3,450USD£2,667GBP
- Report
- October 2022
- 209 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Report
- September 2022
- 134 Pages
From €3140EUR$3,450USD£2,667GBP
- Report
- September 2022
- 150 Pages
Africa, Middle East
From €3140EUR$3,450USD£2,667GBP
- Report
- September 2022
- 157 Pages
Europe
From €3140EUR$3,450USD£2,667GBP
- Report
- September 2022
- 181 Pages
Asia Pacific
From €3140EUR$3,450USD£2,667GBP
- Report
- September 2022
- 127 Pages
North America
From €3140EUR$3,450USD£2,667GBP
- Report
- August 2022
- 104 Pages
From €3140EUR$3,450USD£2,667GBP
- Report
- August 2022
- 112 Pages
Africa, Middle East
From €3140EUR$3,450USD£2,667GBP
- Report
- August 2022
- 124 Pages
Asia Pacific
From €3140EUR$3,450USD£2,667GBP
- Report
- July 2022
- 120 Pages
North America
From €3140EUR$3,450USD£2,667GBP
- Report
- July 2022
- 132 Pages
Europe
From €3140EUR$3,450USD£2,667GBP
- Report
- July 2022
- 122 Pages
United Kingdom
From €3140EUR$3,450USD£2,667GBP
- Report
- June 2022
- 277 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Report
- March 2022
- 198 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Report
- November 2021
- 243 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Report
- February 2024
- 150 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- November 2023
- 167 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- November 2023
- 166 Pages
Global
From €2275EUR$2,500USD£1,933GBP

The Vaccines market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of vaccines. Vaccines are used to prevent and treat infectious diseases, and are an important part of public health initiatives. Vaccines are typically developed by pharmaceutical companies, and then approved by regulatory bodies such as the US Food and Drug Administration (FDA).
The Vaccines market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies are involved in the development, production, and distribution of a wide range of vaccines, including those for influenza, measles, mumps, rubella, and hepatitis. Smaller companies are also involved in the Vaccines market, such as Emergent BioSolutions and Bavarian Nordic. Show Less Read more